A Phase IV, Randomized, Open-label Study to Evaluate One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens (Zagreb 2-1-1 and Essen 1-1-1-1-1) in Chinese Children The purpose of this study is to evaluate the 1 year immunogenicity ...
Reduced vaccination regimens such as the 2-1-1 have been proven to be efficient in raising protective antibody responses. Reduction in the total volume of rabies vaccine is also possible by using the intradermal route of injection, provided the vaccine is administered at several sites. The ...
Ph. Eur. 6.2 (Rabies Vaccine for Human Use Prepared in Cell Cultures; Vaccinum Rabiei ex Cellulis ad Usum Humanum; Rabies Vaccine BP 2008). A sterile freeze-dried suspension of inactivat- ed rabies virus; a suitable strain is grown in an approved cell cul- ture. The cell-culture medium...
NOBIVAC®3-RABIES IS A SAFE CHOICE Proven to be uniformly safe in experimental tests, with no significant adverse reactions in extensive clinical trials.1 ADMINISTRATION AND DOSAGE Subcutaneous or intramuscular 1 mL injection for dogs Subcutaneous 1 mL injection for cats and ferrets Administer a sin...
Rabies is avaccine-preventable diseasecaused by a virus that can be transmitted from animals to humans. It affects the central nervous system ofboth wild and domestic mammalssuch as dogs, cats, foxes and others, and can also infect humans.Domestic dogsare the source of infection in approximately...
There have been many types of rabies vaccines produced since the original vaccine was developed by Pasteur, and several reviews have dealt with the history of the vaccine [1–3]. The vaccines that are available today for use in dogs can be divided into 3 groups; the modified live virus (...
Oral rabies vaccine-laden baits, with a tetracycline biomarker, were distributed in Pinellas County (Florida, USA) by helicopter drop and from cars from Ja... CA Olson,KD Mitchell,PA Werner - 《J Wildl Dis》 被引量: 151发表: 2000年 Acceptance of simulated oral rabies vaccine baits by urb...
Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757–65. ...
Background The United States of America (USA) does not have a national reporting system for rabies post-exposure prophylaxis (PEP). We describe the epidemi... Kira A. Christian a,Jesse D. Blanton b,Michael Auslander c,... - 《Vaccine》 被引量: 86发表: 2009年 Epidemiology, clinical featu...
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (DULUTH, GEORGIA, US) Claims: What is claimed is: 1. A vaccine composition comprising an attenuated recombinant viral vector and an adjuvant, wherein the vector is cable of expressing in an animal host one or more immunogens, and wherein the presen...